LIVN News and Press, LivaNova PLC From 05/23/24

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Vladimir Makatsaria, Chief Executive Officer, will present in a fireside chat at the Goldman Sachs Healthcare Conference in Miami, Florida. The presentation will take place at 1:20 p.m. Eastern Time on Monda...

2024-05-12 10:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-05-12 09:46:02 ET Summary LivaNova has streamlined operations and increased income by shutting down ANTHEM trials and releasing new, premium products. Operating margins have improved from 10% to 18% due to savings in R&D and the mix effects from Essenz. LIVN's epileps...

A look at the top 10 most actives in the United States PROSHARES TRUST (SQQQ) rose 2.3% to $12.22 on volume of 208,602,591 shares CytomX Therapeutics Inc. (CTMX) rose 214.7% to $5.13 on volume of 203,288,355 shares Akanda Corp. (AKAN) rose 25.4% to $0.1166 on volume of 179,349,234 shares ...

2024-05-01 10:56:02 ET LivaNova PLC (LIVN) Q1 2024 Earnings Conference Call May 01, 2024 08:00 AM ET Company Participants Matthew Dodds - Senior Vice President, Corporate Development & IT Vladimir Makatsaria - Chief Executive Officer Alex Shvartsburg - Chief ...

A look at the top 10 most actives in the United States Akanda Corp. (AKAN) rose 52.9% to $0.1422 on volume of 108,274,564 shares CytomX Therapeutics Inc. (CTMX) rose 71.8% to $2.8 on volume of 31,588,176 shares Getaround Inc. (GETR) rose 35.9% to $0.2754 on volume of 26,693,135 shares P...

Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...

2024-05-01 06:12:35 ET More on LivaNova PLC LivaNova issues notice to U.S. patients regarding cybersecurity incident Seeking Alpha’s Quant Rating on LivaNova PLC Read the full article on Seeking Alpha For further details see: LivaNova beats top-lin...

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today reported results for the quarter ended March 31, 2024 and raised full-year 2024 revenue and adjusted diluted earnings per share guidance. Financial Summary and Highlights (1) First-quarter revenu...

2024-04-30 12:08:52 ET More on LivaNova PLC LivaNova PLC (LIVN) Q4 2023 Earnings Call Transcript LivaNova PLC 2023 Q4 - Results - Earnings Call Presentation LivaNova issues notice to U.S. patients regarding cybersecurity incident LivaNova gains after positive...